Evoli, Amelia http://orcid.org/0000-0003-0282-8787
Antonini, Giovanni
Antozzi, Carlo
DiMuzio, Antonio
Habetswallner, Francesco
Iani, Cesare
Inghilleri, Maurizio
Liguori, Rocco
Mantegazza, Renato
Massa, Roberto
Pegoraro, Elena
Ricciardi, Roberta
Rodolico, Carmelo
Article History
Received: 16 November 2018
Accepted: 31 January 2019
First Online: 18 February 2019
Compliance with ethical standards
:
: Amelia Evoli served on an advisory board for Alexion and as jury member for research grant award for Grifols.Giovanni Antonini received conference honoraries from Kedrion, Sanofi-Genzyme and travel grants from Kedrion, Sanofi-Genzyme, Pfizer, Almylan.Carlo Antozzi has no conflicts of interest to disclose.Antonio Di Muzio has no conflicts of interest to disclose.Francesco Habetswallner has no conflicts of interest to disclose.Cesare Iani has no conflicts of interest to disclose.Maurizio Inghilleri has no conflicts of interest to disclose.Rocco Liguori served on advisory boards for Biogen, Sanofi-Genzyme, Argon Healthcare s.r.l., Editree Eventi s.r.l., received Lecture fees from Dynamicom Education, SIMG Service, Adnkronos Salute unipersonale s.r.l., DOC Congress s.r.l., First Class s.r.l., and is a consultant for Alfasigma and Amicus Therapeutics s.r.l.Renato Mantegazza has received funding for travel or meeting attendance from: Sanofi-Aventis, Teva, Biomarin, Alexion, Argenx, Novartis, Catalyst, Merck, and for advisory boards or SSC from: Biomarin, Alexion, Argenx.Roberto Massa received Travel grants from Sanofi-Genzyme, CSL-Behring, Pfizer, Almylan.Elena Pegoraro reports personal fees from PTC Therapeutics, Santhera, Roche and Sanofi-Genzyme.Roberta Ricciardi has no conflicts of interest to disclose.Carmelo Rodolico has no conflicts of interest to disclose.